Zhou Yaping, He Yining, Zhu Peiqi, Yan Ruxue, Tang Ruijie, Wang Lanhui, He Weiming
Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China.
Sci Rep. 2025 Jul 1;15(1):21807. doi: 10.1038/s41598-025-07586-2.
This research pursues a systematic review and meta-analysis concerning the cardiovascular event risk prediction models for maintenance hemodialysis patients. Through systematic literature searching, the titles and abstracts of 23,707 related papers were initially screened, ultimately including 16 papers covering 17 prediction models. The results reveal that among these models, a total of 16 predictive variables were chosen at least twice, with age, diabetes history, and history of cardiovascular disease being the primary predictors. Regarding model validation, 14 models underwent internal validation, 3 models underwent external validation, while 3 models were not subjected to any form of validation. Additionally, calibration testing was performed on 14 models. Risk of bias assessment showed that only 1 model was rated as low risk bias, while the other models were rated as high risk bias due to issues with study cohort characteristics and methodology. Meta-analysis results showed that the combined C-statistic for 13 prediction models was 0.80 (95%CI = 0.74, 0.86), and no significant publication bias was detected. Thus, future construction and validation of prediction models should strictly follow reliable methodological standards and enhance external validation to provide more reliable evidence-based guidance for predicting cardiovascular event risk in maintenance hemodialysis patients.
本研究对维持性血液透析患者心血管事件风险预测模型进行了系统评价和荟萃分析。通过系统的文献检索,初步筛选了23707篇相关论文的标题和摘要,最终纳入16篇论文,涵盖17个预测模型。结果显示,在这些模型中,共有16个预测变量被至少选用两次,其中年龄、糖尿病史和心血管疾病史是主要预测因素。在模型验证方面,14个模型进行了内部验证,3个模型进行了外部验证,3个模型未进行任何形式的验证。此外,对14个模型进行了校准测试。偏倚风险评估显示,只有1个模型被评为低风险偏倚,其他模型由于研究队列特征和方法学问题被评为高风险偏倚。荟萃分析结果显示,13个预测模型的合并C统计量为0.80(95%CI = 0.74, 0.86),未检测到明显的发表偏倚。因此,未来预测模型的构建和验证应严格遵循可靠的方法学标准,加强外部验证,为预测维持性血液透析患者心血管事件风险提供更可靠的循证指导。